Stay updated with breaking news from Robertl Nussbaum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Invitae Co. (NYSE:NVTA – Free Report) have been given a consensus recommendation of “Reduce” by the eleven analysts that are currently covering the stock, Marketbeat reports. Five equities research analysts have rated the stock with a sell rating and six have issued a hold rating on the company. The average 12 month target […]
Nikko Asset Management Americas Inc. lessened its holdings in Invitae Co. (NYSE:NVTA – Get Rating) by 0.1% in the 4th quarter, Holdings Channel.com reports. The fund owned 17,256,161 shares of the medical research company’s stock after selling 19,190 shares during the period. Nikko Asset Management Americas Inc. owned approximately 0.07% of Invitae worth $32,096,000 as […]
Swiss National Bank increased its holdings in Invitae Co. (NYSE:NVTA – Get Rating) by 4.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 539,600 shares of the medical research company’s stock after buying an additional 23,100 shares during […]
Stock analysts at StockNews.com assumed coverage on shares of Invitae (NYSE:NVTA – Get Rating) in a research note issued on Thursday. The firm set a “sell” rating on the medical research company’s stock. A number of other research analysts also recently commented on the company. The Goldman Sachs Group downgraded Invitae from a “neutral” rating […]
Invitae (NYSE:NVTA – Get Rating) had its price target decreased by Piper Sandler from $1.75 to $1.50 in a research report released on Monday, The Fly reports. A number of other analysts have also weighed in on the stock. StockNews.com began coverage on shares of Invitae in a research note on Thursday, March 16th. They […]